Stock ACOG ALPHA COGNITION INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Alpha Cognition Inc. Toronto S.E.

Equities

ACOG

CA02074J2048

Biotechnology & Medical Research

End-of-day quote Toronto S.E.
Other stock markets
 		5-day change 1st Jan Change
- CAD -.--% Intraday chart for Alpha Cognition Inc. -.--% -.--%
Apr. 04 Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period MT
Apr. 04 Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 51.77 13.28 58.93
Enterprise Value (EV) 1 41.54 12.4 58.74
P/E ratio -2.33 x -1.22 x -3.42 x
Yield - - -
Capitalization / Revenue - - -
EV / Revenue - - -
EV / EBITDA -3.77 x -0.95 x -6.05 x
EV / FCF -6,029,520 x -3,351,407 x -10,953,526 x
FCF Yield -0% -0% -0%
Price to Book 5.73 x -10.1 x -12.5 x
Nbr of stocks (in thousands) 60,607 61,023 118,209
Reference price 2 0.8542 0.2176 0.4985
Announcement Date 4/28/22 3/8/23 4/3/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales - - - - -
EBITDA 1 -5.082 -5.688 -11.03 -13.13 -9.706
EBIT 1 -5.161 -5.769 -11.12 -13.22 -9.79
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -6.607 -5.784 -19.55 -12.11 -13.77
Net income 1 -6.607 -5.784 -19.55 -12.11 -13.77
Net margin - - - - -
EPS 2 -0.2100 -0.1347 -0.3665 -0.1782 -0.1460
Free Cash Flow - -1.226 -6.89 -3.701 -5.363
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 4/29/21 4/29/21 4/28/22 3/8/23 4/3/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 - - - - - - - - - -
EBITDA - - - - - - - - - -
EBIT - -5.457 - -5.717 -3.843 -4.639 - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - -4.041 - -3.887 -2.791 -5.676 - - - -
Net income - -4.041 - -3.887 -2.791 -5.676 - -3.781 - -
Net margin - - - - - - - - - -
EPS - -0.0898 - -0.0647 -0.0538 -0.0689 - -0.0406 - -
Dividend per Share - - - - - - - - - -
Announcement Date 11/26/21 4/28/22 5/30/22 8/25/22 11/28/22 3/8/23 5/30/23 8/22/23 11/28/23 4/3/24
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 4.64 2.71 10.2 0.87 0.18
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -1.23 -6.89 -3.7 -5.36
ROE (net income / shareholders' equity) - -220% -432% -314% 457%
ROA (Net income/ Total Assets) - -48.6% -65.2% -104% -226%
Assets 1 - 11.9 29.96 11.61 6.081
Book Value Per Share 2 0.0500 0 0.1500 -0.0200 -0.0400
Cash Flow per Share 2 0.0500 0.1400 0.1900 0.0300 0.0100
Capex - 0.01 0.01 0 -
Capex / Sales - - - - -
Announcement Date 4/29/21 4/29/21 4/28/22 3/8/23 4/3/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.65 CAD
Average target price
1 CAD
Spread / Average Target
+53.85%
Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ACOG Stock
  4. ACOG Stock
  5. Financials Alpha Cognition Inc.